Rhumbline Advisers Trans Medics Group, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 66,319 shares of TMDX stock, worth $4.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

66,319

Previous 47,645 39.19%

Holding current value

$4.03 Million

Previous $7.18 Million 45.09%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$135.68 - $176.11 $2.53 Million - $3.29 Million	18,674 Added 39.19%	66,319 $10.4 Million
Q2 2024 Aug 01, 2024	BUY	$72.62 - $150.62 $129,481 - $268,555	1,783 Added 3.89%	47,645 $7.18 Million
Q1 2024 May 09, 2024	BUY	$70.86 - $89.93 $21,328 - $27,068	301 Added 0.66%	45,862 $3.39 Million
Q4 2023 Feb 08, 2024	SELL	$36.74 - $81.08 $37,989 - $83,836	-1,034 Reduced 2.22%	45,561 $3.6 Million
Q3 2023 Nov 09, 2023	BUY	$53.47 - $96.07 $60,046 - $107,886	1,123 Added 2.47%	46,595 $2.55 Million
Q2 2023 Aug 08, 2023	BUY	$66.23 - $88.73 $199,749 - $267,609	3,016 Added 7.1%	45,472 $3.82 Million
Q1 2023 May 11, 2023	BUY	$53.63 - $82.33 $129,838 - $199,320	2,421 Added 6.05%	42,456 $3.22 Million
Q4 2022 Feb 14, 2023	BUY	$39.08 - $64.29 $150,536 - $247,645	3,852 Added 10.65%	40,035 $2.47 Million
Q3 2022 Nov 10, 2022	BUY	$31.56 - $55.75 $165,185 - $291,795	5,234 Added 16.91%	36,183 $1.51 Million
Q2 2022 Aug 11, 2022	BUY	$20.56 - $32.15 $118,096 - $184,669	5,744 Added 22.79%	30,949 $973,000
Q1 2022 May 12, 2022	BUY	$12.58 - $26.94 $20,392 - $43,669	1,621 Added 6.87%	25,205 $679,000
Q4 2021 Feb 10, 2022	SELL	$19.16 - $32.68 $7,108 - $12,124	-371 Reduced 1.55%	23,584 $452,000
Q3 2021 Nov 12, 2021	BUY	$25.92 - $34.51 $30,222 - $40,238	1,166 Added 5.12%	23,955 $793,000
Q2 2021 Aug 05, 2021	SELL	$21.63 - $40.07 $14,081 - $26,085	-651 Reduced 2.78%	22,789 $756,000
Q1 2021 May 06, 2021	SELL	$17.75 - $47.82 $15,726 - $42,368	-886 Reduced 3.64%	23,440 $973,000
Q4 2020 Feb 10, 2021	BUY	$11.91 - $19.9 $33,395 - $55,799	2,804 Added 13.03%	24,326 $484,000
Q3 2020 Nov 12, 2020	BUY	$13.78 - $18.84 $2,948 - $4,031	214 Added 1.0%	21,522 $297,000
Q2 2020 Aug 13, 2020	BUY	$11.66 - $18.26 $94,212 - $147,540	8,080 Added 61.08%	21,308 $382,000
Q1 2020 May 06, 2020	BUY	$10.5 - $20.2 $24,895 - $47,894	2,371 Added 21.84%	13,228 $160,000
Q4 2019 Feb 05, 2020	BUY	$16.61 - $21.64 $180,334 - $234,945	10,857 New	10,857 $206,000

Others Institutions Holding TMDX

# of Institutions

394

Shares Held

31.7M

Call Options Held

466K

Put Options Held

286K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $1.94B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Trans Medics Group, Inc. Transaction History